Dissecting Water, Sanitation, and Hygiene (WaSH) to Assess Risk Factors for Cholera in Shashemene, Oromia Region, Ethiopia.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
12 Jul 2024
Historique:
medline: 12 7 2024
pubmed: 12 7 2024
entrez: 12 7 2024
Statut: ppublish

Résumé

Cholera outbreaks have afflicted Ethiopia, with nearly 100 000 cases and 1030 deaths reported from 2015 to 2023, emphasizing the critical need to understand water, sanitation, and hygiene (WaSH) risk factors. We conducted a cross-sectional household (HH) survey among 870 HHs in Shashemene Town and Shashemene Woreda, alongside extracting retrospective cholera case data from the Ethiopian Public Health Institute database. Relationships between WaSH and sociodemographic/economic-levels of HHs were examined. WaSH status and cholera attack rates (ARs) were described at kebele-level using geospatial mapping, and their association was statistically analyzed. Access to basic drinking water, sanitation, and hygiene facilities was limited, with 67.5% (95% confidence interval, 64.4-70.6), 73.4% (70.3-76.3), and 30.3% (27.3-33.3) of HHs having access, respectively. Better WaSH practices were associated with urban residence (adjusted odds ratio, 1.7, [95% confidence interval, 1.1-2.7]), higher educational levels (2.7 [1.2-5.8]), and wealth (2.5 [1.6-4.0]). The association between cholera ARs and at least basic WaSH status was not statistically significant (multiple R2 = 0.13; P = .36), although localized effects were suggested for sanitation (Moran I = 0.22; P = .024). Addressing gaps in WaSH access and hygiene practices is crucial for reducing cholera risk. Further analyses with meaningful covariates and increased sample sizes are necessary to understand the association between cholera AR and specific WaSH components.

Sections du résumé

BACKGROUND BACKGROUND
Cholera outbreaks have afflicted Ethiopia, with nearly 100 000 cases and 1030 deaths reported from 2015 to 2023, emphasizing the critical need to understand water, sanitation, and hygiene (WaSH) risk factors.
METHODS METHODS
We conducted a cross-sectional household (HH) survey among 870 HHs in Shashemene Town and Shashemene Woreda, alongside extracting retrospective cholera case data from the Ethiopian Public Health Institute database. Relationships between WaSH and sociodemographic/economic-levels of HHs were examined. WaSH status and cholera attack rates (ARs) were described at kebele-level using geospatial mapping, and their association was statistically analyzed.
RESULTS RESULTS
Access to basic drinking water, sanitation, and hygiene facilities was limited, with 67.5% (95% confidence interval, 64.4-70.6), 73.4% (70.3-76.3), and 30.3% (27.3-33.3) of HHs having access, respectively. Better WaSH practices were associated with urban residence (adjusted odds ratio, 1.7, [95% confidence interval, 1.1-2.7]), higher educational levels (2.7 [1.2-5.8]), and wealth (2.5 [1.6-4.0]). The association between cholera ARs and at least basic WaSH status was not statistically significant (multiple R2 = 0.13; P = .36), although localized effects were suggested for sanitation (Moran I = 0.22; P = .024).
CONCLUSIONS CONCLUSIONS
Addressing gaps in WaSH access and hygiene practices is crucial for reducing cholera risk. Further analyses with meaningful covariates and increased sample sizes are necessary to understand the association between cholera AR and specific WaSH components.

Identifiants

pubmed: 38996037
pii: 7712957
doi: 10.1093/cid/ciae274
doi:

Substances chimiques

Drinking Water 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S53-S62

Subventions

Organisme : Korea Support Committee
Organisme : for IVI
Organisme : LG Electronics
Organisme : Government of the Republic of Korea
Organisme : Swedish International Development Cooperation Agency

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Déclaration de conflit d'intérêts

Potential conflicts of interest. The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Auteurs

Dejene Hailu (D)

Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.
School of Public Health, Hawassa University, Hawassa, Ethiopia.

Yeonji Jeon (Y)

Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.

Abel Gedefaw (A)

Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.
College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia.

Jong-Hoon Kim (JH)

Epidemiology, Public Health, Impact (EPIC) Unit, International Vaccine Institute, Seoul, Republic of Korea.

Ramzi Mraidi (R)

Epidemiology, Public Health, Impact (EPIC) Unit, International Vaccine Institute, Seoul, Republic of Korea.

Tomas Getahun (T)

Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.

Ondari D Mogeni (OD)

Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.

Edlawit Mesfin Getachew (E)

Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.

Geun Hyeog Jang (GH)

Epidemiology, Public Health, Impact (EPIC) Unit, International Vaccine Institute, Seoul, Republic of Korea.

David Mukasa (D)

Epidemiology, Public Health, Impact (EPIC) Unit, International Vaccine Institute, Seoul, Republic of Korea.

Gi Deok Pak (GD)

Epidemiology, Public Health, Impact (EPIC) Unit, International Vaccine Institute, Seoul, Republic of Korea.

Deok Ryun Kim (DR)

Epidemiology, Public Health, Impact (EPIC) Unit, International Vaccine Institute, Seoul, Republic of Korea.

Samuyel Ayele Abebe (S)

Statistics and Data Management Department, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.

Biruk Yeshitela (B)

Bacterial and Viral Disease Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.

Moti Edosa (M)

Public Health Emergency Management, Ethiopia Public Health Institute, Addis Ababa, Ethiopia.

Yeshambel Worku Demlie (Y)

Public Health Emergency Management, Ethiopia Public Health Institute, Addis Ababa, Ethiopia.

Se Eun Park (SE)

Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.
Department of Global Health and Disease Control, Yonsei University Graduate School of Public Health, Seoul, Republic of Korea.

Mekonnen Teferi (M)

Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH